PAS
XPH icon

Park Avenue Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Park Avenue Securities’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$591K Sell
8,917
-3,129
-26% -$183K ﹤0.01% 1216
2026
Q1 		$652K Buy
12,046
+32
+0.3% +$1.78K 0.01% 998
2025
Q4 		$673K Buy
12,014
+1,903
+19% +$98.6K 0.01% 978
2025
Q3 		$485K Buy
+10,111
New +$452K ﹤0.01% 1199

Other funds holding XPH

FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
FFA
Fragasso Financial Advisors Sewickley, Pennsylvania $1.88B AUM 23.81% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Park Avenue Securities's XPH Position: Q2 2026 in Review

Park Avenue Securities reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 26% in Q2 2026, selling an estimated $183K and leaving 8,917 shares worth $591K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

Park Avenue Securities first reported a position in XPH in Q3 2025 and has held it in 4 quarters since. The position peaked at $673K in Q4 2025. 24 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • Park Avenue Securities held 8,917 shares of State Street SPDR S&P Pharmaceuticals ETF worth $591K as of Q2 2026.
  • Park Avenue Securities sold 3,129 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $183K.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1216 holding.
  • Park Avenue Securities first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2025 and has held it in 4 quarters since.
  • Park Avenue Securities's State Street SPDR S&P Pharmaceuticals ETF position peaked at $673K in Q4 2025.
  • 24 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.